R562Q (p.Arg562Gln) variant of SMO (Protein smoothened)
R562Q (p.Arg562Gln) in SMO (Protein smoothened) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Basal cell carcinoma, somatic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data, published literature, and structural context.
R562Q (p.Arg562Gln) variant details
- p.Arg562Gln
- rs121918348
- ClinGen CA119304
- NCI-TCGA Cosmic COSV5084
- ClinVar RCV000008587
- Pathogenic
- Basal cell carcinoma, somatic
- Missense
- Variant Prioritization Score for Impact Estimate 0.672
- REVEL 0.55
- CADD 32.00
- PolyPhen-2 0.98
- SIFT 0.01
- ClinVar: Pathogenic (Basal cell carcinoma, somatic)
- EBI: Pathogenic (in basal cell carcinoma samples)
- UniProt: Pathogenic (in basal cell carcinoma samples)
- Most common in the Middle Eastern population (allele frequency 0.00017)
- Structural context available
- Cited in: Activating Smoothened mutations in sporadic basal-cell carcinoma. (PMID 9422511)